BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dionisi F, Widesott L, Lorentini S, Amichetti M. Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review. Radiotherapy and Oncology 2014;111:1-10. [DOI: 10.1016/j.radonc.2014.02.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Siregar H, Bäumer C, Blanck O, Chan M, Engwall E, Plaude S, Spaan B, Timmermann B, Wulff J. Mitigation of motion effects in pencil-beam scanning – Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma. Zeitschrift für Medizinische Physik 2020. [DOI: 10.1016/j.zemedi.2020.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Lin SY, Chen CM, Huang BS, Lai YC, Pan KT, Lin SM, Chu SY, Tseng JH. A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness. PLoS One 2021;16:e0249003. [PMID: 33755701 DOI: 10.1371/journal.pone.0249003] [Reference Citation Analysis]
3 Brasse D, Burckel H, Marchand P, Rousseau M, Ouadi A, Vanstalle M, Finck C, Laquerriere P, Boisson F. Comparison of the [18F]-FDG and [18F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular Carcinoma. Mol Imaging Biol 2021;23:724-32. [PMID: 33847900 DOI: 10.1007/s11307-021-01602-3] [Reference Citation Analysis]
4 Qi WX, Fu S, Zhang Q, Guo XM. Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis. Radiother Oncol. 2015;114:289-295. [PMID: 25497556 DOI: 10.1016/j.radonc.2014.11.033] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
5 Hsu CY, Wang CW, Cheng AL, Kuo SH. Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness. World J Gastrointest Oncol 2019; 11(8): 579-588 [PMID: 31435460 DOI: 10.4251/wjgo.v11.i8.579] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
6 Durante M. Charged particles for liver cancer. Ann Transl Med 2015;3:363. [PMID: 26807418 DOI: 10.3978/j.issn.2305-5839.2015.12.32] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Dionisi F, Ben-josef E. The Use of Proton Therapy in the Treatment of Gastrointestinal Cancers: Liver. The Cancer Journal 2014;20:371-7. [DOI: 10.1097/ppo.0000000000000082] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
8 Lin L, Souris K, Kang M, Glick A, Lin H, Huang S, Stützer K, Janssens G, Sterpin E, Lee JA, Solberg TD, McDonough JE, Simone CB 2nd, Ben-Josef E. Evaluation of motion mitigation using abdominal compression in the clinical implementation of pencil beam scanning proton therapy of liver tumors. Med Phys 2017;44:703-12. [PMID: 28133755 DOI: 10.1002/mp.12040] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
9 Choi C, Son A, Lee GH, Shin SW, Park S, Ahn SH, Chung Y, Yu JI, Park HC. Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction. PLoS One 2019;14:e0218049. [PMID: 31194786 DOI: 10.1371/journal.pone.0218049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
10 Kim TH, Park JW, Kim BH, Kim DY, Moon SH, Kim SS, Lee JH, Woo SM, Koh YH, Lee WJ, Kim CM. Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma. Oncotarget. 2017;9:4034-4043. [PMID: 29423102 DOI: 10.18632/oncotarget.23428] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
11 Kim TH, Park JW, Kim BH, Kim H, Moon SH, Kim SS, Woo SM, Koh YH, Lee WJ, Kim DY, Kim CM. Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma? Cancers (Basel). 2019;11. [PMID: 30781391 DOI: 10.3390/cancers11020230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
12 Mizumoto M, Oshiro Y, Okumura T, Fukuda K, Fukumitsu N, Abei M, Ishikawa H, Ohnishi K, Numajiri H, Tsuboi K, Sakurai H. Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy. Radiother Oncol 2014;113:54-9. [PMID: 25248924 DOI: 10.1016/j.radonc.2014.08.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
13 Wu YY, Fan KH. Proton therapy for prostate cancer: current state and future perspectives. Br J Radiol 2021;:20210670. [PMID: 34558308 DOI: 10.1259/bjr.20210670] [Reference Citation Analysis]
14 Bodine EN, Monia KL. A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma. Math Biosci Eng 2017;14:881-99. [PMID: 28608702 DOI: 10.3934/mbe.2017047] [Reference Citation Analysis]
15 Knox JJ, Cleary SP, Dawson LA. Localized and Systemic Approaches to Treating Hepatocellular Carcinoma. JCO 2015;33:1835-44. [DOI: 10.1200/jco.2014.60.1153] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 4.9] [Reference Citation Analysis]
16 Hajj C, Goodman KA. Role of Radiotherapy and Newer Techniques in the Treatment of GI Cancers. JCO 2015;33:1737-44. [DOI: 10.1200/jco.2014.59.9787] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
17 Spychalski P, Kobiela J, Antoszewska M, Błażyńska-Spychalska A, Jereczek-Fossa BA, Høyer M. Patient specific outcomes of charged particle therapy for hepatocellular carcinoma - A systematic review and quantitative analysis. Radiother Oncol 2019;132:127-34. [PMID: 30825961 DOI: 10.1016/j.radonc.2018.12.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
18 Kim DY, Park JW, Kim TH, Kim BH, Moon SH, Kim SS, Woo SM, Koh YH, Lee WJ, Kim CM. Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis. Radiother Oncol. 2017;122:122-129. [PMID: 28034460 DOI: 10.1016/j.radonc.2016.12.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
19 Dionisi F, Brolese A, Siniscalchi B, Giacomelli I, Fracchiolla F, Righetto R, Morganti AG, Pravadelli C, Avancini I, Rozzanigo U, Mattiuzzi A, Frisinghelli M, Pertile R, Ciarleglio FA, Vitale A, Schwarz M, Amichetti M. Clinical results of active scanning proton therapy for primary liver tumors. Tumori 2021;107:71-9. [PMID: 32648818 DOI: 10.1177/0300891620937809] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Richter C, Pausch G, Barczyk S, Priegnitz M, Keitz I, Thiele J, Smeets J, Stappen FV, Bombelli L, Fiorini C, Hotoiu L, Perali I, Prieels D, Enghardt W, Baumann M. First clinical application of a prompt gamma based in vivo proton range verification system. Radiotherapy and Oncology 2016;118:232-7. [DOI: 10.1016/j.radonc.2016.01.004] [Cited by in Crossref: 138] [Cited by in F6Publishing: 102] [Article Influence: 23.0] [Reference Citation Analysis]
21 Chun S, Nam K, Lee K. Proton Beam Induces P53-mediated Cell Cycle Arrest in HepG2 Hepatocellular Carcinoma Cells. Biotechnol Bioproc E 2020;25:141-8. [DOI: 10.1007/s12257-019-0390-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Yoo GS, Yu JI, Park HC. Current role of proton beam therapy in patients with hepatocellular carcinoma. Int J Gastrointest Interv 2021;10:175-82. [DOI: 10.18528/ijgii210043] [Reference Citation Analysis]
23 Colvill E, Petersen JBB, Hansen R, Worm E, Skouboe S, Høyer M, Poulsen PR. Validation of fast motion-including dose reconstruction for proton scanning therapy in the liver. Phys Med Biol 2018;63:225021. [PMID: 30457119 DOI: 10.1088/1361-6560/aaeae9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Takamatsu S, Yamamoto K, Maeda Y, Kawamura M, Shibata S, Sato Y, Terashima K, Shimizu Y, Tameshige Y, Sasaki M, Asahi S, Kondou T, Kobayashi S, Matsui O, Gabata T. Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging. PLoS One 2016;11:e0167155. [PMID: 27907063 DOI: 10.1371/journal.pone.0167155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
25 Shinoto M, Ebner DK, Yamada S. Particle Radiation Therapy for Gastrointestinal Cancers. Curr Oncol Rep 2016;18:17. [PMID: 26849660 DOI: 10.1007/s11912-016-0499-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
26 Pham TT, Whelan B, Oborn BM, Delaney GP, Vinod S, Brighi C, Barton M, Keall P. Magnetic resonance imaging (MRI) guided proton therapy: A review of the clinical challenges, potential benefits and pathway to implementation. Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2022.02.031] [Reference Citation Analysis]
27 Hsieh CE, Venkatesulu BP, Lee CH, Hung SP, Wong PF, Aithala SP, Kim BK, Rao A, Tung-Chieh Chang J, Tsang NM, Wang CC, Lee CC, Lin CC, Tseng JH, Chou WC, Wang YC, Krishnan S, Hong JH. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy. Int J Radiat Oncol Biol Phys. 2019;105:73-86. [PMID: 30797890 DOI: 10.1016/j.ijrobp.2019.02.032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
28 Yoo GS, Yu JI, Park HC. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives. World J Gastroenterol 2018; 24(28): 3090-3100 [PMID: 30065555 DOI: 10.3748/wjg.v24.i28.3090] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
29 Tsang DS, Craig T, Mishra L, Dawson LA. In Regard to Sanford et al. Int J Radiat Oncol Biol Phys 2019;105:230-1. [PMID: 31422810 DOI: 10.1016/j.ijrobp.2019.03.009] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Yoo GS, Yu JI, Cho S, Jung SH, Han Y, Park S, Oh Y, Lee B, Park HC, Lim DH, Choi MS, Won H. Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma. Radiother Oncol 2020;146:187-93. [PMID: 32179362 DOI: 10.1016/j.radonc.2020.02.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
31 Hwang EJ, Gorayski P, Le H, Hanna GG, Kenny L, Penniment M, Buck J, Thwaites D, Ahern V. Particle therapy toxicity outcomes: A systematic review. J Med Imaging Radiat Oncol 2020;64:725-37. [PMID: 32421259 DOI: 10.1111/1754-9485.13036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Culleton S, Jiang H, Haddad CR, Kim J, Brierley J, Brade A, Ringash J, Dawson LA. Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma. Radiother Oncol. 2014;111:412-417. [PMID: 24906626 DOI: 10.1016/j.radonc.2014.05.002] [Cited by in Crossref: 121] [Cited by in F6Publishing: 109] [Article Influence: 15.1] [Reference Citation Analysis]
33 Sekino Y, Okumura T, Fukumitsu N, Iizumi T, Numajiri H, Mizumoto M, Nakai K, Nonaka T, Ishikawa H, Sakurai H. Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus. J Cancer Res Clin Oncol 2020;146:711-20. [PMID: 31776663 DOI: 10.1007/s00432-019-03096-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
34 Fracchiolla F, Dionisi F, Righetto R, Widesott L, Giacomelli I, Cartechini G, Farace P, Bertolini M, Amichetti M, Schwarz M. Clinical implementation of pencil beam scanning proton therapy for liver cancer with forced deep expiration breath hold. Radiother Oncol 2021;154:137-44. [PMID: 32976870 DOI: 10.1016/j.radonc.2020.09.035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]